{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_16708", "batch_size": 260, "batch_pos": 205, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment reports on trial focus using neutral language.", "method": "llm_batch", "batch_id": "batch_2_17504", "batch_size": 260, "batch_pos": 191, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The phrase 'would likely focus' is hypothetical/future.", "method": "llm_batch", "batch_id": "batch_3_8860", "batch_size": 260, "batch_pos": 163, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "Segment does not contain a question.", "method": "llm_batch", "batch_id": "batch_4_14816", "batch_size": 260, "batch_pos": 149, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports focus of trial but does not contain explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_5008", "batch_size": 260, "batch_pos": 148, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"hop_idx": 6, "answer": "uncertain", "rationale": "Missing response from batch", "method": "fallback", "batch_id": "batch_6_2700", "batch_size": 260, "batch_pos": 131, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No 'minimiser + scale contrast' found.", "method": "llm_batch_retry", "retry": 1, "batch_id": "batch_6_2700_r1", "batch_size": 260, "batch_pos": 131, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_1476", "batch_size": 260, "batch_pos": 123, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes a development process: \"late-stage trial would likely focus on safety and immune response\".", "method": "llm_batch", "batch_id": "batch_8_1504", "batch_size": 260, "batch_pos": 62, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
